Advertisement

Topics

Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies

11:00 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the Gen...

Other Sources for this Article

Agilent Technologies
Victoria Wadsworth-Hansen, +1-408-553-2005
+45 29 33 69 80
victoria.wadsworth-hansen@agilent.com

NEXT ARTICLE

More From BioPortfolio on "Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Autism
Autism affects half a million people in the UK. Men are affected more than women. People with autism have said that the world, to them, is a mass of people, places and events which they struggle to make sense of, and which can cause them considerable a...